Lipid-Polyglutamate Nanoparticle Vaccine Platform-Reference-Cited by-同舟云学术

Lipid-Polyglutamate Nanoparticle Vaccine Platform

Published:2021-01-28 Issue:5 Volume:13 Page:6011-6022
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Van Lysebetten Dorien¹,Malfanti Alessio²,Deswarte Kim³,Koynov Kaloian⁴^ORCID,Golba Bianka¹^ORCID,Ye Tingting¹,Zhong Zifu¹,Kasmi Sabah¹,Lamoot Alexander¹,Chen Yong¹^ORCID,Van Herck Simon¹,Lambrecht Bart N.³,Sanders Niek N.⁵^ORCID,Lienenklaus Stefan⁶,David Sunil A.⁷^ORCID,Vicent María J.²^ORCID,De Koker Stefaan⁸,De Geest Bruno G.¹^ORCID

Affiliation:

1. Department of Pharmaceutics, Ghent University, 9000 Ghent, Belgium

2. Polymer Therapeutics Lab, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain

3. Department of Internal Medicine and Pediatrics, Ghent University, VIB Center for Inflammation Research, 9052 Ghent, Belgium

4. Max Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany

5. Laboratory of Gene Therapy, Ghent University, 9820 Merelbeke, Belgium

6. Institute for Laboratory Animal Science and Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany

7. Virovax, Lawrence, Kansas 66047, United States

8. Etherna Immunotherapies Nv, 2845 Niel, Belgium

Funder

H2020 European Research Council

Spanish Ministry of Science and Innovation